We offer a unique model of an international clinical CRO, providing “Full-Service” support to manufacturers of medical devices, biotechs, medtechs, and pharmaceutical companies for the development of interventional and non-interventional clinical trials, both exploratory and confirmatory, as well as post-authorization real-world studies (Market Access/HEOR, secondary database analyses…).

With 440 regional experts and 13 official offices across North and South America and Europe, including Lyon for France, our organization is a personalized alternative to large CROs. We deliver the highest professional added value, with the scale to manage any type of clinical development program while maintaining the flexibility and attention that every international study deserves.